7.47
Journey Medical Corp 주식(DERM)의 최신 뉴스
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Can Zhejiang Taimei Medical Technology Co. Ltd. (A2V) stock ride next bull market cycleMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
Can Unidoc Health Corp. (L7T) stock beat analyst consensusJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - Улправда
Is Journey Medical Corporation stock a buy on dipsEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
How analysts rate Quipt Home Medical Corp. stock todayWeekly Gains Report & Accurate Trade Setup Notifications - Улправда
Fortress Biotech (Nasdaq: FBIO): FDA accepts Class 1 resubmission, CUTX-101 PDUFA Jan. 14, 2026 - Stock Titan
Fortress Biotech (NASDAQ: FBIO) extends loan maturity and grants warrants - Stock Titan
Journey Medical announces results from phase 1 trial of DFD-29 - MSN
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Minocycline study shows no microbiome disruption after 16-week use By Investing.com - Investing.com Nigeria
Journey Medical announces results from Phase 1 trial of DFD-29 - TipRanks
DERM FinancialsIncome Statement - Quiver Quantitative
Minocycline study shows no microbiome disruption after 16-week use - Investing.com India
Journey Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety Issues - Quiver Quantitative
Journey Medical (Nasdaq: DERM) posts Phase 1 Emrosi data on 16-week microbiome profile - Stock Titan
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis - TradingView — Track All Markets
DERM Stock On The Rise: Worth Watching As Emrosi Adoption Expands - RTTNews
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Strategic Wealth LLC Takes $250,000 Position in HCA Healthcare, Inc. $HCA - MarketBeat
VITAS Healthcare (CHE) shares caregiver Stacy Noland's hospice-at-home story in new video - Stock Titan
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation $DERM - MarketBeat
New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home - Yahoo Finance
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Head-To-Head Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Journey Medical (NASDAQ:DERM) - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS) - The Globe and Mail
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo! Finance Canada
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Is Journey Medical Corporation forming a reversal patternFed Meeting & Low Drawdown Trading Strategies - newser.com
FY2029 EPS Estimates for Journey Medical Boosted by Analyst - Defense World
What valuation multiples suggest for Journey Medical Corporation stockPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
Can Journey Medical Corporation stock deliver sustainable ROEQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
B. Riley Increases Earnings Estimates for Journey Medical - MarketBeat
HC Wainwright Forecasts Weaker Earnings for Journey Medical - MarketBeat
자본화:
|
볼륨(24시간):